GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $140.80 $156.84 Wednesday, 17th Apr 2024 ASND stock ended at $142.17. This is 0.473% more than the trading day before Tuesday, 16th Apr 2024. During the day the stock fluctuated 2.45% from a day low at $140.80 to a day high of $144.25.
90 days $128.67 $161.00
52 weeks $66.03 $161.00

Historical Ascendis Pharma A/S prices

Date Open High Low Close Volume
2021-05-27 $134.28 $136.21 $133.00 $136.19 284 591
2021-05-26 $133.54 $136.37 $131.38 $133.77 213 316
2021-05-25 $134.85 $134.85 $131.56 $132.59 209 509
2021-05-24 $139.00 $139.00 $134.33 $135.09 146 682
2021-05-21 $138.59 $138.83 $135.14 $137.23 133 179
2021-05-20 $135.22 $142.00 $133.90 $137.47 171 869
2021-05-19 $137.43 $141.70 $132.54 $134.62 229 791
2021-05-18 $135.00 $141.30 $133.67 $138.12 258 900
2021-05-17 $131.92 $135.99 $130.02 $135.63 100 954
2021-05-14 $128.07 $132.95 $127.97 $132.18 177 159
2021-05-13 $136.64 $137.67 $126.86 $127.24 194 566
2021-05-12 $133.59 $137.29 $130.81 $136.96 161 481
2021-05-11 $127.44 $134.67 $126.58 $133.64 218 548
2021-05-10 $132.32 $132.32 $128.66 $130.07 121 005
2021-05-07 $134.68 $136.77 $131.28 $132.90 86 437
2021-05-06 $138.01 $139.49 $132.09 $132.90 189 481
2021-05-05 $139.99 $139.99 $134.49 $138.18 373 588
2021-05-04 $144.47 $144.47 $134.64 $138.39 579 827
2021-05-03 $144.93 $148.62 $142.15 $145.29 174 621
2021-04-30 $140.98 $147.85 $140.98 $144.97 355 317
2021-04-29 $138.82 $141.96 $135.38 $141.96 224 644
2021-04-28 $136.01 $138.53 $134.65 $138.27 102 948
2021-04-27 $136.11 $136.84 $134.01 $136.31 175 083
2021-04-26 $131.78 $136.84 $131.45 $135.65 186 953
2021-04-23 $133.16 $135.56 $130.01 $132.07 200 985
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT